Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

escin, ethyleneglycol monosalicylate, heparin drug combination MeSH Supplementary Concept Data 2025


MeSH Supplementary
escin, ethyleneglycol monosalicylate, heparin drug combination
Unique ID
C012094
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C012094
Entry Term(s)
Venostatin
escin - ethyleneglycol monosalicylate - heparin
escin, mixt. with heparin sodium salt & 2- hydroxyethyl 2-hydroxybenzoate
Registry Numbers
0
Heading Mapped to
Drug Combinations
*Escin
*Heparin
*Salicylates
Frequency
4
Note
combination of aescin, heparin & ethyleneglycol monosalicylate used in topical treatment of edema, hematoma
Source
Z Allg Med 51(14):684;1975
Date of Entry
1976/01/01
Revision Date
2010/10/22
escin, ethyleneglycol monosalicylate, heparin drug combination Preferred
Venostatin Narrower
page delivered in 0.004s